Aesthetic Treatment Peptides Australia is approached at Core Aesthetics through individual consultation, not a standard protocol. An aesthetic consultation reviews the concern, medical history, timing, expectations, risk factors and whether treatment is appropriate. The aim is to make a careful decision before any plan is discussed. A consultation may lead to treatment planning, a decision to wait, referral, or a recommendation not to proceed.
In early 2026, a new injectable trend is circulating on social media and in online wellness communities. Injectable peptides, compounds including GHK-Cu, BPC-157, and TB-500, among others, are being promoted for anti ageing, skin repair, and a range of cosmetic and physical enhancement claims. The content is confident, the sourcing is online, and the practitioners administering these products span a wide range of qualifications.
This article is not an advertisement for or against any particular product or trend. It is a clinical overview of what injectable peptides are, where they sit in the Australian regulatory framework, and what patients considering any form of injectable treatment should understand before making a decision.
Core Aesthetics uses only TGA approved Schedule 4 prescription medicines, prescribed and administered by Corey Anderson, AHPRA registered nurse (NMW0001047575). The position here is simple: if a substance is not TGA approved for the intended use, it is not used.
What Injectable Peptides Are
Peptides are short chains of amino acids, the building blocks of proteins. The human body produces peptides naturally; they are involved in a wide range of biological functions including wound healing, immune response, hormone signalling, and cellular regulation.
Some peptides have legitimate medical research applications. BPC-157, for example, has been studied in animal models for gastrointestinal healing and tissue repair. GHK-Cu appears in research related to skin wound healing. TB-500 has been investigated in animal models of cardiac repair.
The leap from animal model research to ‘inject this into your face at a beauty clinic’ is a significant one, and it is being made commercially without the clinical evidence base that TGA approval requires. The mechanisms by which these compounds are hypothesised to work in humans are not yet established by peer reviewed human clinical trials for cosmetic application.
TGA Safety Alert. April 2026
In April 2026, the TGA issued a formal safety alert stating it was concerned about a significant increase in the importation and supply of unapproved peptide products in Australia. The alert named compounds including BPC-157, GHK-Cu, and TB-500 as products being sold and administered without TGA approval for their intended uses.
The TGA’s documented adverse events from unapproved injectable peptides include severe allergic reactions requiring hospitalisation, intense full body itching, palpitations, blurred vision, pain, insomnia, and musculoskeletal injury. These are not theoretical risks. They are documented outcomes from people who received these compounds outside a regulated clinical setting.
The alert distinguished these products from TGA approved prescription medicines. Unapproved peptide products have not been assessed by the TGA for quality, safety, or efficacy in their intended use. Australian Border Force and TGA enforcement actions in 2026 have included the seizure of peptide stockpiles and charges relating to their importation and distribution.
If you see a clinic, wellness provider, or online service offering injectable peptide treatments in Australia, asking whether the specific compound has TGA approval for that use is not an unreasonable question. It is the right one. The TGA’s public alert is available at tga.gov.au for patients who want to read it directly.
The Australian Regulatory Gap
In Australia, medicines for injection are regulated by the Therapeutic Goods Administration (TGA). Aesthetic treatments administered by registered health practitioners, wrinkle treatments and facial volume treatments, are Schedule 4 prescription medicines. They require a prescription from an authorised prescriber, a consultation, and administration by a registered health practitioner in a clinical setting.
Injectable peptides being sold online and promoted on social media do not fall into this regulatory category. Many are sold as research chemicals or peptide compounds without therapeutic claims, a framing that places them outside standard TGA oversight of listed medicines, while also meaning they lack the safety and efficacy data that TGA approval requires.
This is not a technicality. The regulatory framework exists because injection of compounds directly into the body bypasses the normal absorption barriers that protect against adverse reactions. A compound that has not passed the TGA’s assessment for injectable human use has not had its safety profile, purity standards, or correct dosing established for that context.
UNSW’s April 2026 analysis of the injectable peptide trend notes the absence of human clinical trial evidence for the anti ageing claims being made. The Conversation published the same analysis in the same week. Both are worth reading if you are considering this category of product.
Why This Is Relevant to Aesthetic treatment Patients
Patients researching aesthetic treatments in Australia in 2026 may encounter peptide injection services being offered alongside or instead of TGA approved cosmetic treatments. They may be offered by aestheticians, wellness practitioners, or people who are not registered health practitioners. They may be offered in beauty salons, via home visits, or through online subscription services.
The clinical concerns are specific. Any injection carries the risk of infection, vascular injury, and adverse reaction. These risks are managed in clinical settings by registered practitioners with the training and equipment to respond to adverse events. In non clinical settings, they are not.
The absence of TGA approval for a compound is an absence of evidence, not simply a regulatory technicality. Patients considering any injectable product are entitled to ask: is this TGA approved for this use in Australia? Is the person administering it a registered health practitioner? Is there a consultation before any injection takes place? These are the same questions to ask about any aesthetic treatment.
Core Aesthetics is a clinical injectable practice. The treatments offered here are TGA approved prescription medicines, prescribed individually at consultation by Corey Anderson, AHPRA registered nurse. The basis for that choice is clinical, not commercial.
Questions to Ask Before Any Injectable Treatment
Whether you are considering a TGA approved aesthetic treatment or anything else, these are the questions that protect your safety:
Is this product TGA approved for this use in Australia? Not approved overseas. Not approved in general. Approved in Australia for this specific application.
Is the person administering it a registered health practitioner? You can check AHPRA registration at ahpra.gov.au. Registration is publicly searchable. If the person cannot be found, they are not registered.
Is there a consultation before the injection? A consultation is the point at which medical history, contraindications, and suitability are assessed. No responsible clinical injectable practice performs treatment without a prior consultation.
What is the clinical response plan if something goes wrong? Registered clinical practitioners are required to have appropriate emergency equipment and training to manage adverse events. Ask what the protocol is.
These questions apply to all injectables, including the treatments Corey Anderson offers. Transparency about the regulatory and clinical basis of any injectable treatment is the standard by which a practice should be judged.
A Note on Core Aesthetics’ Practice
Core Aesthetics is a TGA-compliant aesthetic treatment clinic. The treatments available here are prescription wrinkle treatment and prescription facial volume treatment, both individually assessed at a consultation with Corey Anderson, AHPRA registered nurse (NMW0001047575, registered since January 1996).
No injectable peptides or non-TGA approved compounds are used, offered, or endorsed at Core Aesthetics. This is a clinical position based on regulatory compliance and patient safety, not a marketing claim.
If you are considering aesthetic treatment and want to understand what you are being offered before committing to it, a consultation at Core Aesthetics is available. The consultation will tell you what treatment is or is not appropriate for your situation, including whether treatment is not recommended at this time.
Is this for you?
Consider booking a consultation if
- You want to understand aesthetic consultation before deciding whether treatment is appropriate
- You are 18 or older and want an individual clinical assessment
- You value a consultation-first approach with risk and suitability discussed before planning
- You are open to waiting or not proceeding if that is the safer recommendation
This may not be for you if
- You are seeking a promised outcome or a same-day decision without assessment
- You are under 18 years of age
- You are pregnant, trying to conceive or breastfeeding and are seeking elective aesthetic treatment
- You have an active infection, unhealed skin or an unresolved medical concern in the area to be assessed
Suitability is confirmed at consultation. This list is general guidance, not a substitute for clinical assessment.
Frequently asked questions
What happens during an initial assessment at Core Aesthetics?
Attendance at Core Aesthetics begins with a clinical assessment by Corey Anderson RN that covers the presenting concern, medical history, current medications, prior treatment and suitability. This assessment forms the basis for any recommendation. Treatment is not performed at the consultation appointment.
How does Core Aesthetics’ consultation-first model work?
Core Aesthetics applies a consultation-first model to all patients. This means individual assessment precedes any treatment plan. The consultation for concerns described in topics like this establishes what is present, what may be appropriate and what the realistic outcome range is before any decision is made.
What does Core Aesthetics require before any treatment is considered?
A full individual assessment is required before treatment is considered. This covers medical history, current medications, prior treatment, the specific concern and suitability.
What is Core Aesthetics’ policy on the period between consultation and treatment?
At Core Aesthetics, consultation precedes any treatment decision. The consultation is structured to allow patients adequate time to understand the assessment findings and discuss timing before any treatment plan is agreed.
What factors can lead to no treatment being recommended after assessment?
Assessment may result in no treatment recommendation when the concern is outside the scope of injectable options, when anatomy or medical factors make treatment unsuitable, or when expectations cannot be met. This outcome is honest and acceptable. Not every consultation at Core Aesthetics leads to a treatment plan.
What information is helpful to bring to a consultation?
A current medication list, details of any prior treatment in the relevant area, how long the concern has been present, how it has changed and any specific questions help the consultation be efficient. Photographs showing how the area has changed over time are also useful where relevant.
How does Corey Anderson RN approach each individual assessment?
Corey Anderson RN assesses each patient from first principles. Concerns of the type described here are evaluated in the context of individual anatomy, medical history and realistic expectations. A standard protocol is not applied. The recommendation reflects what the individual assessment supports, not what is typical or most common.
How does the two-appointment process at Core Aesthetics work?
New patients at Core Aesthetics attend a consultation as the first appointment. If treatment is recommended and agreed, a further appointment is scheduled to proceed with treatment when the patient is ready. This two-appointment structure is applied consistently at Core Aesthetics as a matter of clinic practice and patient care.